Press Releases on October 17, 2023 - EIN Presswire - Press Release Distribution Service

Published on October 17, 2023 - 20:05 GMT

Beyond Air® To Participate in the Truist Securities BioPharma Symposium

GARDEN CITY, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide ( …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on October 17, 2023 - 20:05 GMT

PetIQ, Inc. to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

EAGLE, Idaho, Oct. 17, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the third quarter ended September 30, 2023, on …

Distribution channels:

Published on October 17, 2023 - 20:05 GMT

Akero Therapeutics to Present at the H.C. Wainwright 7th Annual NASH Virtual Investor Conference

SOUTH SAN FRANCISCO, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, today …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on October 17, 2023 - 20:04 GMT

Preferred Bank Reports Quarterly Earnings

LOS ANGELES, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC), one of the larger independent California banks, today reported results for the quarter ended September 30, 2023. Preferred Bank (“the Bank”) reported net income of $38.2 million …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 17, 2023 - 20:02 GMT

Ultragenyx Announces Proposed Public Offering of Common Stock

NOVATO, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today announced that it has …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on October 17, 2023 - 20:01 GMT

The Real Good Food Company, Inc. Announces the Full Exercise of the Overallotment Option

CHERRY HILL, N.J., Oct. 17, 2023 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (NASDAQ: RGF) (the “Company”), a leading health and wellness frozen and refrigerated food company, today announced that the underwriter of the Company’s previously …

Distribution channels:

Published on October 17, 2023 - 20:01 GMT

CarGurus To Report Third Quarter 2023 Financial Results

CAMBRIDGE, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, announced it will issue a press release reporting financial results for the …

Distribution channels:

Published on October 17, 2023 - 20:01 GMT

Data From Two Studies Demonstrating Positive Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed ...

Abstracts for cost-effectiveness data and budget-impact model published in the Journal of Managed Care & Specialty Pharmacy (JMCP) INPEFA recently approved by FDA for treatment of heart failure THE WOODLANDS, Texas, Oct. 17, 2023 (GLOBE NEWSWIRE) -- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...